Los Altos, CA, United States of America

S Russ Lehrman

This inventor holds 1 USPTO granted patent. Top assignee: Nektar Therapeutics. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: S Russ Lehrman. Retrieved from https://idiyas.com/inventor/s-russ-lehrman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: S Russ Lehrman: Innovator in Inhaleable Protein Powders

Introduction

S Russ Lehrman is a notable inventor based in Los Altos, CA. He has made significant contributions to the field of aerosolized drug delivery systems. His innovative work focuses on creating highly dispersible spray-dried powder compositions for inhalation.

Latest Patents

One of his key patents is titled "Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation." This invention provides highly dispersible spray-dried powder compositions, particularly for aerosolized delivery to the lungs. The powders are produced by spray drying a 4-helix bundle protein under conditions that protect the protein from aggregation while ensuring the particles are suitable for inhalation, demonstrating superior aerosol performance. He holds 1 patent for this groundbreaking work.

Career Highlights

S Russ Lehrman is associated with Nektar Therapeutics, a company known for its innovative approaches in drug delivery. His work at Nektar Therapeutics has positioned him as a key player in the development of inhalable therapies.

Collaborations

He has collaborated with notable coworkers, including Cynthia L Stevenson and Jayne E Hastedt, contributing to advancements in their respective fields.

Conclusion

S Russ Lehrman's contributions to inhalable protein powders represent a significant advancement in aerosolized drug delivery systems. His innovative approach continues to influence the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…